The OMERACT MRI inflammatory arthritis group: advances and future research priorities.
The OMERACT magnetic resonance imaging (MRI) in inflammatory arthritis group previously developed the rheumatoid arthritis MRI score (RAMRIS) for use in clinical studies, evaluated the use of extremity MRI, and initiated development of a psoriatic arthritis MRI score (PsAMRIS). At OMERACT 9 the group looked at clarifications of applying the RAMRIS, and presented data from a study examining how the contrast agent gadolinium affects RAMRIS outcomes. Much of the group's effort has been aimed at the iterative development of its PsA score, and reported exercises examining this score demonstrated encouraging results, allowing subsequent presentation of a preliminary PsAMRIS. The large amount of data presented were followed by discussions with the wider audience highlighting constructive suggestions for future research priorities, including further feasibility studies, understanding imaging remission, and further improvements to PsAMRIS.
Conaghan
Philip G
PG
Section of Musculoskeletal Disease, Chapel Allerton Hospital, Leeds, UK. p.conaghan@leeds.ac.uk
Bird
Paul
P
McQueen
Fiona
F
Peterfy
Charles
C
Bøyesen
Pernille
P
Gandjbakhch
Frédérique
F
Duer-Jensen
Anne
A
Haavardsholm
Espen A
EA
Ejbjerg
Bo
B
Wiell
Charlotte
C
Coates
Laura
L
Hermann
Kay-Geert A
KG
O'Connor
Philip
P
Lassere
Marissa
M
Freeston
Jane E
JE
Anandarajah
Allen
A
Genant
Harry
H
Emery
Paul
P
Ostergaard
Mikkel
M
D015535:Arthritis, Psoriatic / Q000473:pathology*; D001172:Arthritis, Rheumatoid / Q000473:pathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D012106:Research / Q000639:trends*; D012219:Rheumatology / Q000639:trends*